The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease

The chitinase-like protein YKL-40 was found to be increased in patients with severe asthma and chronic obstructive pulmonary disease (COPD), two disease conditions featuring neutrophilic infiltrates. Based on these studies and a previous report indicating that neutrophils secrete YKL-40, we hypothesized that YKL-40 plays a key role in cystic fibrosis (CF) lung disease, a prototypic neutrophilic disease. The aim of this study was (i) to analyze YKL-40 levels in human and murine CF lung disease and (ii) to investigate whether YKL-40 single-nucleotide polymorphisms (SNPs) modulate CF lung disease severity. YKL-40 protein levels were quantified in serum and sputum supernatants from CF patients and control individuals. Levels of the murine homologue BRP-39 were analyzed in airway fluids from CF-like βENaC-Tg mice. YKL-40SNPs were analyzed in CF patients. YKL-40 levels were increased in sputum supernatants and in serum from CF patients compared to healthy control individuals. Within CF patients, YKL-40 levels were higher in sputum than in serum. BRP-39 levels were increased in airways fluids from βENaC-Tg mice compared to wild-type littermates. In both CF patients and βENaC-Tg mice, YKL-40/BRP-39 airway levels correlated with the severity of pulmonary obstruction. Two YKL-40 SNPs (rs871799 and rs880633) were found to modulate age-adjusted lung function in CF patients. YKL-40/BRP-39 levelsare increased in human and murine CF airway fluids, correlate with pulmonary function and modulate CF lung disease severity genetically. These findings suggest YKL-40 as a potential biomarker in CF lung disease.

[1]  V. Bhandari,et al.  The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. , 2010, American journal of respiratory and critical care medicine.

[2]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[3]  M. Griese,et al.  Novel Method to Process Cystic Fibrosis Sputum for Determination of Oxidative State , 2009, Respiration.

[4]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[5]  R. Flavell,et al.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis , 2009, The Journal of experimental medicine.

[6]  C. Lee.  Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling , 2009, Yonsei medical journal.

[7]  G. Chupp,et al.  Novel biomarkers in asthma: chemokines and chitinase-like proteins , 2009, Current opinion in allergy and clinical immunology.

[8]  P. Kiener,et al.  YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages1 , 2008, The Journal of Immunology.

[9]  A. Gaggar,et al.  TLR Expression on Neutrophils at the Pulmonary Site of Infection: TLR1/TLR2-Mediated Up-Regulation of TLR5 Expression in Cystic Fibrosis Lung Disease1 , 2008, The Journal of Immunology.

[10]  I. Christensen,et al.  Serum levels of YKL-40 increases in patients with acute myocardial infarction , 2008, Coronary artery disease.

[11]  Ying Sun,et al.  Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. , 2008, The New England journal of medicine.

[12]  L. Herzenberg,et al.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways , 2008, Proceedings of the National Academy of Sciences.

[13]  D. Roos,et al.  Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. , 2008, The Journal of allergy and clinical immunology.

[14]  C. Rudolph,et al.  Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease , 2007, Nature Medicine.

[15]  J. Dziura,et al.  A chitinase-like protein in the lung and circulation of patients with severe asthma. , 2007, The New England journal of medicine.

[16]  B. Jensen,et al.  Is YKL-40 a new therapeutic target in cancer? , 2007, Expert opinion on therapeutic targets.

[17]  M. Schluchter,et al.  Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. , 2006, American journal of respiratory and critical care medicine.

[18]  R. Homer,et al.  Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. , 2005, The Journal of allergy and clinical immunology.

[19]  S. Weiland,et al.  G-Protein-coupled receptor polymorphisms are associated with asthma in a large German population. , 2005, American journal of respiratory and critical care medicine.

[20]  P. Kristjansen,et al.  Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. , 2005, Lung cancer.

[21]  A. Wiik,et al.  High serum levels of YKL‐40 in patients with systemic sclerosis are associated with pulmonary involvement , 2005, Scandinavian journal of rheumatology.

[22]  S. Wenzel.  Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both? , 2004, American journal of respiratory and critical care medicine.

[23]  Richard C Boucher,et al.  Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice , 2004, Nature Medicine.

[24]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. , 2002, The Biochemical journal.

[25]  J. Lundgren,et al.  YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis , 2002, Clinical and Vaccine Immunology.

[26]  K. Ostergaard,et al.  Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. , 2001, Osteoarthritis and cartilage.

[27]  H. Nielsen,et al.  YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. , 1998, Proceedings of the Association of American Physicians.

[28]  P. Sasieni.  From genotypes to genes: doubling the sample size. , 1997, Biometrics.

[29]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[30]  L. Shackelton,et al.  Identification of a 38-kDa Heparin-binding Glycoprotein (gp38k) in Differentiating Vascular Smooth Muscle Cells as a Member of a Group of Proteins Associated with Tissue Remodeling (*) , 1995, The Journal of Biological Chemistry.

[31]  Brian,et al.  Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. , 1993, The Journal of biological chemistry.

[32]  W. Hurley,et al.  Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. , 1988, Biochemical and biophysical research communications.

[33]  M. Decramer,et al.  Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. , 2010, American journal of respiratory cell and molecular biology.

[34]  S. Randell,et al.  Highlights of a workshop to discuss targeting inflammation in cystic fibrosis. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[35]  Frédéric Massicotte,et al.  Mammalian chitinase-like proteins. , 1999, EXS.

[36]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[37]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.